Physician profile
Micah Tepper
NPI 1114973963
$949.90
in general payments reported to CMS, 2019-2025
14 companies · $58.53 in 2025
The $58.53 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $138 · 2021: $111 · 2022: $109 · 2023: $202 · 2024: $131 · 2025: $58.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $392.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $391.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $405.83 | 2019-2024 | |
| Janssen Pharmaceuticals, INC | $86.76 | 2020-2021 | |
| Pfizer INC. | $82.28 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $80.99 | 2019-2022 | |
| Amgen INC. | $67.57 | 2020-2022 | |
| Boston Scientific Corporation | $49.69 | 2023-2025 | General - Therapies, Watchman Flx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $28.68 | 2023 | Lifevest |
| Abbott Laboratories | $24.90 | 2023 | Cardiomems |
| Innovation Technologies INC | $24.73 | 2025 | Irrisept |
| Astrazeneca Pharmaceuticals Lp | $23.41 | 2021 | |
| Medtronic Vascular, INC. | $21.29 | 2020 | |
| Amarin Pharma, INC. | $20.18 | 2019 | |
| Merck Sharp & Dohme LLC | $17.59 | 2021 | |
| Esperion Therapeutics, INC. | $16.00 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Micah Tepper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.